A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

• Egile Nagusiak: Dandan Sun (Egilea), Yifang Zou (Egilea), Liu Song (Egilea), Shulan Han (Egilea), Hao Yang (Egilea), Di Chu (Egilea), Yun Dai (Egilea), Jie Ma (Egilea), Caitriona M. O'Driscoll (Egilea), Zhuo Yu (Egilea), Jianfeng Guo (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2022-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The immune checkpoint blockade therapy has profoundly revolutionized the field of cancer immunotherapy. However, despite great promise for a variety of cancers, the efficacy of immune checkpoint inhibitors is still low in colorectal cancer (CRC). This is mainly due to the immunosuppressive feature o...